TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TXMD
benzinga.comAugust 26, 2024
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy
TXMD
Zacks Investment ResearchApril 14, 2023
TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.